Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A series of articles that set out to explore the global distribution of infections that cause non-malarial febrile illness has been published in BMC Medicine. The series brings together the results of large-scale systematic reviews of the causes of fever in Africa, Latin America, and Southern and South-Eastern Asia, and has helped identify major knowledge gaps, geographical differences, priority areas for diagnostics research and development, and enabled the most comprehensive systematic review of literature to date.

Mother and newborn © Arne Hoel World Bank

Febrile illness is the most common reason for childhood healthcare visits globally, with hundreds of millions of cases of fever in 0 to four-year-olds presenting at health facilities every year. Historically, in malaria-endemic countries it was assumed that malaria was the cause of fever, but with the advent of rapid diagnostic tests (RDTs) for malaria, combined with intensified malaria control activities over the last decade, the incidence rate of malaria has been substantially reduced. Health workers and researchers have noted that once malaria is ruled out, it is difficult to diagnose febrile illness due to limited diagnostic tools, laboratory facilities and the scarcity of comprehensive surveillance networks in low-resource settings. Thus, patients with fever are often misdiagnosed and given inappropriate treatments, such as antibiotics in the absence of a confirmed diagnosis, which in addition to mistreating individual patients may contribute to antimicrobial resistance.

Today, the ongoing pandemic of COVID-19, a disease with a potential presentation of non-specific febrile illness, further highlights the need for accurate diagnostics, strong surveillance networks and standardized data to efficiently handle this disease alongside addressing the multitudes of causes of potentially co-existing non-malarial febrile illnesses.

In order to map the main causes of fever in all malaria-endemic regions, researchers associated with the WorldWide Antimalarial Resistance Network (WWARN); the Infectious Diseases Data Observatory (IDDO) at the University of Oxford, the Foundation for Innovative New Diagnostics (FIND), London School of Hygiene & Tropical Medicine (LSHTM), University of Otago, University of Hong Kong, Fundação Oswaldo Cruz (Fiocruz), and the MORU Tropical Health Network - Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU) and Cambodia-Oxford Medical Research Unit (COMRU) screened more than 100,000 articles published between 1980 and 2015 to provide the most comprehensive data available to date.

Read the full story on the IDDO website

Similar stories

Salum Mshamu named a 2026 TIME Trailblazer

Congratulations to Salum Mshamu on being selected as one of TIME’s inaugural 2026 Trailblazers: Designing and Making the Future. A University of Oxford DPhil student, Salum was recognised for his contribution to research showing how improved housing design can reduce malaria and other childhood illnesses.

Oxford, WHO and partners announce next-generation AI initiative to detect, assess and respond to pandemics

The University of Oxford has been awarded €8 million through the European Union’s Horizon Europe programme to coordinate the development of the Pandemics AI Observatory (PANDAI). Led by the University in partnership with the World Health Organization and an international consortium of leading research, public health and technology partners, the three-year project will develop and deploy advanced artificial intelligence (AI) models to transform the detection, assessment, prediction and response to global infectious disease threats.

Behind the Title: Becoming an Oxford Professor (at NDM): Featuring Professor Direk Limmathurotsakul

The Behind the Title: Becoming an Oxford Professor (at NDM) series highlights the diverse journeys of our professors and the many paths that lead to academic leadership. By sharing their journeys we aim to showcase the breadth of backgrounds, disciplines, and experiences represented across the Department, demonstrating that there is no single route to becoming a professor at Oxford.

MODRA Cohort 1: Where they are now and what comes next?

Eighteen months after joining MODRA, our first fellows are leading projects, winning grants, and building new collaborations across the region. Upon completion of the MODRA programme and moving move into the next stage of their careers, here’s a look at how our fellows are turning learning into lasting impact.

Medicine Quality Research Group awarded £3.7 million to evaluate devices for detecting substandard and falsified vaccines

The Medical Research Council (UK) has awarded a £ 3.7 million DPFS grant to expand the work led by the Medicine Quality Research Group on innovative screening devices for detecting degraded and falsified vaccines.

Professor Direk Limmathurotsakul awarded 2026 UNESCO-Carlos J. Finlay Prize for Microbiology

Professor Direk Limmathurotsakul has received the 2026 UNESCO-Carlos J. Finlay Prize for Microbiology. The Prize recognises his contributions to microbiology, particularly his work on melioidosis, antimicrobial-resistant (AMR) infections and turning local data into public health action.

Similar stories

Salum Mshamu named a 2026 TIME Trailblazer

Congratulations to Salum Mshamu on being selected as one of TIME’s inaugural 2026 Trailblazers: Designing and Making the Future. A University of Oxford DPhil student, Salum was recognised for his contribution to research showing how improved housing design can reduce malaria and other childhood illnesses.

Oxford, WHO and partners announce next-generation AI initiative to detect, assess and respond to pandemics

The University of Oxford has been awarded €8 million through the European Union’s Horizon Europe programme to coordinate the development of the Pandemics AI Observatory (PANDAI). Led by the University in partnership with the World Health Organization and an international consortium of leading research, public health and technology partners, the three-year project will develop and deploy advanced artificial intelligence (AI) models to transform the detection, assessment, prediction and response to global infectious disease threats.

Behind the Title: Becoming an Oxford Professor (at NDM): Featuring Professor Direk Limmathurotsakul

The Behind the Title: Becoming an Oxford Professor (at NDM) series highlights the diverse journeys of our professors and the many paths that lead to academic leadership. By sharing their journeys we aim to showcase the breadth of backgrounds, disciplines, and experiences represented across the Department, demonstrating that there is no single route to becoming a professor at Oxford.

MODRA Cohort 1: Where they are now and what comes next?

Eighteen months after joining MODRA, our first fellows are leading projects, winning grants, and building new collaborations across the region. Upon completion of the MODRA programme and moving move into the next stage of their careers, here’s a look at how our fellows are turning learning into lasting impact.

Medicine Quality Research Group awarded £3.7 million to evaluate devices for detecting substandard and falsified vaccines

The Medical Research Council (UK) has awarded a £ 3.7 million DPFS grant to expand the work led by the Medicine Quality Research Group on innovative screening devices for detecting degraded and falsified vaccines.

Professor Direk Limmathurotsakul awarded 2026 UNESCO-Carlos J. Finlay Prize for Microbiology

Professor Direk Limmathurotsakul has received the 2026 UNESCO-Carlos J. Finlay Prize for Microbiology. The Prize recognises his contributions to microbiology, particularly his work on melioidosis, antimicrobial-resistant (AMR) infections and turning local data into public health action.